(Q41040042)

25 September 2017

title

The A/G polymorphism in the -78 position of the apolipoprotein A-I promoter does not have a direct effect on transcriptional efficiency (English)

1 reference

25 September 2017

4

1 reference

25 September 2017

G M Danek

1

1 reference

25 September 2017

M Valenti

series ordinal

2

1 reference

25 September 2017

F E Baralle

series ordinal

3

1 reference

25 September 2017

publication date

1 May 1998

1 reference

25 September 2017

number of pages

8

1 reference

Biochimica et Biophysica Acta

inferred from page(s)

published in

1 reference

25 September 2017

volume

1398

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

67-74

1 reference

Introduction to the plasma lipoproteins

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Lecithin: cholesterol acyltransferase: effects of substrate composition upon enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin. Cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Mouse Models of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

An investigation of the role of lecithin: cholesterol acyltransferase and triglyceride-rich lipoproteins in the metabolism of pre-beta high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

The role of apolipoprotein AI domains in lipid binding

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Transcriptional Control Signals of a Eukaryotic Protein-Coding Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Association of a polymorphism in the Apo AI gene promoter with hyperalphalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Determinants of change in total cholesterol and HDL-C with age: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Metabolic determinants of low HDL-C levels

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Isolation of the human HDL apoprotein A1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Gene structure of human apolipoprotein A1.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: mechanism of antagonism by testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Opposite in vitro and in vivo regulation of hepatic apolipoprotein A-I gene expression by retinoic acid. Absence of effects on apolipoprotein A-II gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2898%2900029-3

7 January 2021

10.1016/S0167-4781(98)00029-3

Identifiers

DOI

1 reference

25 September 2017

1 reference